# Safety, Efficacy Assessment of Geltim LP® 1 mg/g in Ocular Hypertensive or Glaucomatous Patients.

> **NCT01155219** · PHASE4 · COMPLETED · sponsor: **Laboratoires Thea** · enrollment: 150 (actual)

## Conditions studied

- Glaucoma

## Interventions

- **DRUG:** Geltim LP 1 mg/g
- **DRUG:** Xalatan

## Key facts

- **NCT ID:** NCT01155219
- **Lead sponsor:** Laboratoires Thea
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-07
- **Primary completion:** 2009-07
- **Final completion:** 2009-12
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2017-04-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01155219

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01155219, "Safety, Efficacy Assessment of Geltim LP® 1 mg/g in Ocular Hypertensive or Glaucomatous Patients.". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01155219. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*